StrokeJClub
Parent Perspectives on I-ACQUIRE Therapy.
Stroke · · Journal Article · Open access
Yale, Hindery + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
In the US 15-site I-ACQUIRE phase 3 trial for infants/toddlers with perinatal arterial ischemic stroke and hemiparesis, parents reported fewer “no clear benefit” concerns (≤4% vs 18%) than usual treatment.
- Why it matters: Even though Constraint-Induced Movement Therapy is recommended for hemiparesis, parent lived-experience data are limited, despite I-ACQUIRE requiring substantial parent involvement.
- What they did: Across 167 consenting parents, surveys assessed life/therapy stress, concerns, observed child progress, and perceived responsibilities for usual treatment versus moderate-dose I-ACQUIRE (3 h/d, 5 d/wk for 4 weeks) or high-dose I-ACQUIRE (6 h/d).
- The result: Compared with usual treatment, I-ACQUIRE parents showed higher positive feelings that therapy was useful (94%-98% vs 83%), interesting (96%-98% vs 79%), important (94%-98% vs 85%), and fun (78%-84% vs 53%), while treatment-related stress, difficulty, and fatigue remained reported by some parents in all groups.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- Open access
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.